A first-of-its-kind pill for endometriosis has been approved for NHS use, offering hope for people in England suffering from the debilitating condition.
The combination drug, relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill licensed to treat endometriosis.